cognitive cybersecurity intelligence
European biotech stocks continue to disappoint, with half of listed biotechs in the region having just 12 months of cash left. However, a recent report from Bryan, Garnier & Co sees a strong biotech venture capital scene and rallying stocks as reasons to be optimistic.
Biotech…
Source: www.labiotech.eu – Read more
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
Detour Dog malware uses DNS TXT records to hijack 30,000 sites SecurityBrief Australia
Novartis drug Rhapsido is now approved as a second-line treatment for chronic spontaneous urticaria, a rare inflammatory skin disease. Additional clinical trials are ongoing to
Cybersecurity Awareness Month: Recognizing and Responding to Modern Phishing Attacks The University of Maryland, Baltimore
The following hospital and health system CEO departures, including retirements and leadership transitions, have been recently reported by Becker’s. Note: This page was created March
